Other substances

Benserazide

A decarboxylase inhibitor.

Phase of research

Potential treatment - theoretical effect

How it helps

Antiviral

Drug status

Used to treat other disease

1
 Supporting references
0
 Contradictory references
0
 AI-suggested references
0
 Clinical trials

General information

Benserazide is a decarboxylase inhibitor not capable of crossing blood-brain barrier and therefore used as an adjuvant during levodopa therapy to impede its extracerebral activity (ChEBI).

Benserazide on DrugBank
Benserazide on PubChem
Benserazide on Wikipedia

Synonyms

Serazide

Marketed as

MADOPAR; PROLOPA; often foxed-dose with LEVODOPA

 

Structure image - Benserazide

C1=CC(=C(C(=C1CNNC(=O)C(CO)N)O)O)O

Supporting references

Link Tested on Impact factor Notes Publication date
Screening of Therapeutic Agents for COVID-19 Using Machine Learning and Ensemble Docking Studies
Screening 		in silico 6.71

Predicted to bind the SARS-CoV-2 spike protein or spike protein:ACE2 interface.

 Aug/05/2020
Export (.csv)